The Future Will Be Edited
When the coronavirus pandemic emerged in January, bioengineers at Stanford University were working on a system to fight the flu with the gene-editing technology CRISPR. They immediately focused their attention to using CRISPR for fighting COVID 19 and according to their recent report, they’ve developed a way to inhibit 90% of coronaviruses, including SARS-CoV-2, the […]
Read More
Genetic editing or the CRISPR gene-editing method, has raised many controversies since it is currently the most promising technique in health care. Genetically modifying human embryos to eliminate disease-causing genes, should this be allowed? Let’s find out. Arguments for and Against Genetic Editing In February 2016, the second trial involving genetic editing of the human embryo […]
Read More
As the world waits for the coronavirus pandemic curve to be permanently flattened, public health experts mandate that millions of people have to coronavirus testing to determine if states are safe to reopen. While some companies have invented self-contained devices that test for the coronavirus and deliver a result in minutes, they can be costly […]
Read More
CRISPR technology is a core competency for Merck, a leading science and technology company that received its first U.S. patent in February 2019 for its proxy-CRISPR technology making CRISPR more efficient, flexible, and specific. The company continues to develop technologies in a range of genome-editing applications, including gene knockout, gene integration, and CRISPR libraries for […]
Read More
CRISPR screening for coronavirus is in the works. CRISPR screening helps identify genes that cause diseases such as sickle-cell anemia, cancer, and lung cancer metastasis. The technology enables thousands of genes to be modified, helping scientists identify and assess their function in a single experiment. However, CRISPR screening can only target or edit DNA, which […]
Read More
